Prevalence of adverse drug events in ambulatory care: a systematic review.
about
A research agenda on patient safety in primary care. Recommendations by the LINNEAUS collaboration on patient safety in primary careImproving medication safety in primary care. A review and consensus procedure by the LINNEAUS collaboration on patient safety in primary careInformation technology interventions to improve medication safety in primary care: a systematic reviewDrug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literatureImpact of a warning CPOE system on the inappropriate pill splitting of prescribed medications in outpatientsPatterns of Adverse Drug Reactions in Different Age Groups: Analysis of Spontaneous Reports by Community PharmacistsDose-Specific Adverse Drug Reaction Identification in Electronic Patient Records: Temporal Data Mining in an Inpatient Psychiatric PopulationClinical questions raised by providers in the care of older adults: a prospective observational studyLearning from the design, development and implementation of the Medication Safety Thermometer.Medication-related emergency department visits and hospitalizations among older adults.Medication-related visits in a pediatric emergency department: an 8-years retrospective analysis.Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties.A systematic review of hospitalization resulting from medicine-related problems in adult patients.Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.A tailored implementation intervention to implement recommendations addressing polypharmacy in multimorbid patients: study protocol of a cluster randomized controlled trial.Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients.Description and process evaluation of pharmacists' interventions in a pharmacist-led information technology-enabled multicentre cluster randomised controlled trial for reducing medication errors in general practice (PINCER trial).Understanding the causes of intravenous medication administration errors in hospitals: a qualitative critical incident studyEpidemiology of adverse drug reactions in Europe: a review of recent observational studiesNo medicine is sometimes the best medicine.Comparing characteristics of adverse drug events between older and younger adults presenting to a Taiwan emergency departmentAssociation between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study.Trends in hospital admissions due to antidepressant-related adverse drug events from 2001 to 2011 in the U.S.Understanding the implementation and adoption of a technological intervention to improve medication safety in primary care: a realist evaluationComparison of knowledge, attitude and practices of resident doctors and nurses on adverse drug reaction monitoring and reporting in a tertiary care hospital.Optimising drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: improving drug safety in primary healthcare by low eGFR alerts.Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey.Medication Literacy in a Cohort of Chinese Patients Discharged with Acute Coronary Syndrome.Drugs causing adverse events in patients aged 45 or older: a randomised survey of Australian general practice patientsMeaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetesIntroducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study.Potentially high-risk medication categories and unplanned hospitalizations: a case-time-control study.Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy.Adverse drug reactions in elderly hospitalized patients: a 12-year population-based retrospective cohort study.Implementing a clinical pharmacy survey of adverse drug events in a French emergency department.Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes.Risk factors for hospital admissions associated with adverse drug events.Adherence to therapy and adverse drug reactions: is there a link?Understanding the implementation and adoption of an information technology intervention to support medicine optimisation in primary care: qualitative study using strong structuration theory.Drug-Related-Problem Outcomes and Program Satisfaction from a Comprehensive Brown Bag Medication Review.
P2860
Q26784320-0582697E-D36A-4169-838B-3A3792BEC17CQ26784395-045AAD75-18E0-4895-AA55-C20B17DC4F59Q26829102-608B87DE-B64C-4C1D-ACB4-6764DCDE75C8Q27002393-EAB984DF-185E-41E8-86CF-8BB389B5AA93Q28542540-496E1986-FD3D-42DB-934E-B7E686A05288Q28546491-EA365DDF-D19D-451F-B81A-84F00EA71509Q30002404-CAA0D33C-F635-4906-A4A4-69DB8AF59057Q30583422-47A6EB46-42ED-4C1E-974F-ADBBA5023B46Q33623461-3F4AF3FF-C5E6-4AC0-BEAD-AA2844A728ACQ33715099-59251701-F8BF-4622-857F-7E5649FE5980Q33796209-54C4B136-4825-43A9-9EF8-6E29CCF0AC25Q33910107-D13BD8F1-C5B5-4D61-8C69-11D12BB20D10Q34065250-FDA11D31-0328-43E6-B42E-6AC74BE24D51Q34209590-7CD82A2C-7ADA-4B30-A113-4AB67390A55BQ34522926-A1B20B49-2EE9-4E0F-AC01-EABADF9FDF8CQ34555590-3BB2446B-7A66-4036-8E94-433A51CA4C6CQ34822904-B98A6D3A-A351-447A-899D-31A430D69C50Q35179866-E0D7609A-A5A2-4F15-83F7-840745861E29Q35546999-2018B961-9B73-46CA-A5E8-82C59116B57CQ35614946-116C22F5-02D8-41AA-B6EE-B882C2AAF7AFQ36009549-D260E562-7622-4C86-A0CE-FF8C94B06AB3Q36114623-85BA8773-2DA5-49B2-A220-A11EE6D7802DQ36254647-CD02B5AB-46AD-4815-823F-99D394289744Q36306786-2D9E3E54-D227-4751-B7A5-2FCC1EC3B91EQ36470184-1B3EC1FF-C31A-4DA7-A242-DFC1E39ACCCDQ36584160-1D5EBA5B-E081-4EDA-AF8B-B4D7F620AB0AQ36939152-353ACFA5-DD8C-458C-B739-AFE8DBFD084EQ37129010-FA9B5C48-44C8-4DFB-9386-4C4E9A845838Q37228992-47A6DF20-77E2-4F77-8372-9D74AC9A31BDQ37229257-4F97480C-3BA8-4C84-8CEB-CE093BEB96A5Q37306211-9E4FA4BD-E66B-489B-A1B7-9A8E7BF74AD3Q37598383-4ADF3DB9-8A7D-4FCA-8824-05E8E961F7AEQ38016947-1944156A-BC07-4ABB-963E-8C3DFB467F9FQ38022166-8092E1B6-2E89-4B0E-B7F5-F38EA34CF73EQ38038127-80038DCB-872C-4574-AC34-F6B3806E7629Q38061086-327AFBF4-D28D-469C-AD30-872E0A7EC8E3Q38107906-67D7E3E6-F69A-4A44-8AB3-BCD139666742Q38244574-8E5867D3-D883-4050-9086-151DE1EDD12CQ38370844-3BDEC97C-89B3-4F2A-B8E0-8F9DC0FF6A7CQ38575070-9595DB7B-EEBD-45BF-B0CB-68A64E52F6DD
P2860
Prevalence of adverse drug events in ambulatory care: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence of adverse drug events in ambulatory care: a systematic review.
@en
Prevalence of adverse drug events in ambulatory care: a systematic review.
@nl
type
label
Prevalence of adverse drug events in ambulatory care: a systematic review.
@en
Prevalence of adverse drug events in ambulatory care: a systematic review.
@nl
prefLabel
Prevalence of adverse drug events in ambulatory care: a systematic review.
@en
Prevalence of adverse drug events in ambulatory care: a systematic review.
@nl
P2860
P356
P1476
Prevalence of adverse drug events in ambulatory care: a systematic review
@en
P2093
Stephanie V Taché
P2860
P304
P356
10.1345/APH.1P627
P407
P577
2011-06-21T00:00:00Z